GlassScriptPhysician profile
Kenneth M Blue
NPI 1033154968
$1,674.49
in general payments reported to CMS, 2019-2025
19 companies · $84.70 in 2025
The $84.70 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2020: $87.42 · 2021: $228 · 2022: $448 · 2023: $527 · 2024: $168 · 2025: $84.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.54 | 2020-2023 | Lupron Depot |
| Myriad Genetic Laboratories, INC. | $266.44 | 2023-2024 | Prolaris |
| Procept Biorobotics Corporation | $170.30 | 2022-2025 | Aquabeam Robotic System |
| Dendreon Pharmaceuticals LLC | $157.07 | 2019-2022 | |
| Boston Scientific Corporation | $149.92 | 2021-2024 | Solyx Sis System |
| Blue Earth Diagnostics | $142.60 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $131.58 | 2019-2024 | Xiaflex, Aveed |
| Antares Pharma, INC. | $105.57 | 2021-2023 | Nocdurna, Xyosted, Tlando |
| Rochester Medical Corporation | $39.86 | 2022 | |
| Pfizer INC. | $26.91 | 2020-2022 | |
| Acerus Pharmaceuticals Corporation | $25.43 | 2021 | |
| Astellas Pharma US INC | $21.94 | 2024 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $18.88 | 2021 | |
| Tolmar, INC. | $18.47 | 2023 | |
| Dornier Medtech America, INC | $17.84 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $17.15 | 2024 | Adstiladrin |
| Axonics, INC. | $16.16 | 2022 | |
| Coloplast Corp | $15.72 | 2024 | |
| Allergan, INC. | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Blue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.